We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.62B
AUM Growth
-$87M
Cap. Flow
+$163M
Cap. Flow %
6.23%
Top 10 Hldgs %
19.04%
Holding
306
New
25
Increased
130
Reduced
75
Closed
44

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$21.9M
2
MTDR icon
Matador Resources
MTDR
+$20.5M
3
PCRX icon
Pacira BioSciences
PCRX
+$20.3M
4
CRS icon
Carpenter Technology
CRS
+$15.7M
5
HAE icon
Haemonetics
HAE
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 19.07%
3 Industrials 16.32%
4 Consumer Discretionary 15.92%
5 Financials 12.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YETI icon
51
Yeti Holdings
YETI
$3.87B
$20.7M 0.79%
345,333
+33,046
+11% +$2.13M
RAMP icon
52
LiveRamp
RAMP
$2.3B
$19.8M 0.76%
530,186
+24,778
+5% +$1.04M
SNCY
53
DELISTED
Sun Country Airlines
SNCY
$19.8M 0.75%
755,103
+228,140
+43% +$5.95M
MODN
54
DELISTED
MODEL N, INC.
MODN
$19.5M 0.75%
726,491
+61,331
+9% +$1.6M
ARVN icon
55
Arvinas
ARVN
$517M
$19.4M 0.74%
287,776
-30,399
-10% -$2.07M
REPL icon
56
Replimune Group
REPL
$859M
$19.3M 0.73%
1,134,012
+144,054
+15% +$2.72M
CUTR
57
DELISTED
Cutera, Inc.
CUTR
$19.3M 0.73%
+279,035
New +$11.3M
CRS icon
58
Carpenter Technology
CRS
$27.7B
$19.2M 0.73%
457,771
+448,531
+4,854% +$15.7M
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$4.38B
$19.1M 0.73%
788,738
+71,420
+10% +$1.73M
FIVE icon
60
Five Below
FIVE
$11.2B
$18.8M 0.72%
118,862
+9,002
+8% +$1.5M
WHD icon
61
Cactus
WHD
$3.78B
$18.8M 0.72%
331,032
-7,880
-2% -$391K
CCOI icon
62
Cogent Communications
CCOI
$549M
$17.4M 0.66%
262,199
+26,561
+11% +$1.7M
GOSS icon
63
Gossamer Bio
GOSS
$83.2M
$16.9M 0.65%
1,949,577
+178,658
+10% +$1.72M
HAE icon
64
Haemonetics
HAE
$3.54B
$16.9M 0.64%
+267,548
New +$14.5M
TMCI icon
65
Treace Medical Concepts
TMCI
$279M
$16.5M 0.63%
872,279
+493,351
+130% +$9.59M
COLL icon
66
Collegium Pharmaceutical
COLL
$1.17B
$16.3M 0.62%
800,118
+225,281
+39% +$4.26M
RARE icon
67
Ultragenyx Pharmaceutical
RARE
$2.88B
$16.3M 0.62%
223,952
-11,793
-5% -$821K
DIOD icon
68
Diodes
DIOD
$4B
$16.2M 0.62%
186,020
-120,493
-39% -$11M
AMRC icon
69
Ameresco
AMRC
$1.22B
$16M 0.61%
200,824
+67,572
+51% +$4.26M
ARIS
70
DELISTED
Aris Water Solutions
ARIS
$15.2M 0.58%
836,624
+252,544
+43% +$3.66M
LIND icon
71
Lindblad Expeditions
LIND
$1.82B
$15.1M 0.58%
1,004,000
+30,115
+3% +$484K
HRT
72
DELISTED
HireRight Holdings Corporation
HRT
$15.1M 0.58%
883,124
+80,684
+10% +$1.09M
WOOF icon
73
Petco
WOOF
$760M
$14.9M 0.57%
759,302
-418
-0.1% -$7.82K
AIMC
74
DELISTED
Altra Industrial Motion Corp
AIMC
$14.5M 0.55%
373,234
+8,929
+2% +$401K
FARO
75
DELISTED
Faro Technologies
FARO
$14.2M 0.54%
273,298
+25,323
+10% +$1.41M

Similar funds

Emerald Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Emerald Advisers held 306 positions worth $2.62B, down 3.2% from $2.71B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers deployed $163M of net new capital in Q1 2022, opening 25 new positions and adding to 130 existing holdings. Its largest new stake was Shift4: 415,980 shares worth $25.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Eastern Bankshares, an estimated $31.5M trimmed.

  • Emerald Advisers's largest Q1 2022 buy was Shift4: 415,980 shares worth $25.8M.
  • Emerald Advisers added most to Carpenter Technology in Q1 2022, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q1 2022 reduction was Eastern Bankshares, cutting an estimated $31.5M.
  • Emerald Advisers fully exited Cohu in Q1 2022, selling an estimated $20.4M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.62B portfolio in Q1 2022.
  • Emerald Advisers opened 25 new positions and closed 44 in Q1 2022.
  • Emerald Advisers's portfolio value fell 3.2% quarter-over-quarter to $2.62B.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.